Brecht · The Journal of neuroscience : the official journal of the Society for Neuroscience 2004 · Transgenic animal comparative laboratory study · n=?

Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.

Cited 404 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Animal model / bench laboratory research

PubMed 15014128 · doi:10.1523/JNEUROSCI.4315-03.2004 · record verified 2026-08-30

What was done

Researchers examined apoE proteolysis via Western blotting in brain tissue homogenates from transgenic mice expressing human apoE3 or apoE4 specifically in neurons (NSE promoter) or astrocytes (GFAP promoter). They evaluated fragmentation across age, specific brain regions (neocortex, hippocampus, cerebellum), and following excitotoxic challenge with kainic acid. Accumulation of phosphorylated tau (p-tau) and intraneuronal inclusions was also assessed.

What was found

C-terminal-truncated apoE fragments accumulated in an age-dependent pattern in NSE-apoE4 brains and, to a significantly lesser extent, NSE-apoE3 brains; no fragments were detected in GFAP-apoE3 or GFAP-apoE4 mice. Fragmentation was restricted to AD-vulnerable regions (neocortex, hippocampus) and was absent in the cerebellum. Kainic acid excitotoxic challenge significantly increased apoE fragmentation in NSE-apoE4 mice but not in NSE-apoE3 mice. Phosphorylated tau accumulated age-dependently in NSE-apoE4 mice (and to a much lesser extent in NSE-apoE3 mice), while absent in GFAP-apoE mice. Intraneuronal p-tau inclusions in the hippocampus were prominent in 21-month-old NSE-apoE4 mice but barely detectable in NSE-apoE3 mice. Specific numerical values were not reported in the abstract.

Why it matters

This study demonstrates that the generation of neurotoxic C-terminal apoE fragments and downstream tau pathology depends on both the cellular source (neuronal vs. astrocytic) and the isoform (apoE4 vs. apoE3), identifying a potential mechanism linking neuronal apoE4 expression to Alzheimer's pathology.

Limits

The study is limited to animal and in vitro transgenic models driven by cell-specific promoters, which may not fully reflect human endogenous expression patterns. No sample sizes, effect magnitudes, or numerical statistics are provided in the abstract.

Cited by